Related Experiment Video
Updated: Jan 22, 2026

Cardiac Magnetic Resonance Imaging at 7 Tesla
Published on: January 6, 2019
68Ga-NOTA-Aca-BBN(7-14) PET imaging of GRPR in children with optic pathway glioma
Jingjing Zhang1,2,3, Yongji Tian4, Deling Li5
1Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Insights
Gastrin-releasing peptide receptor (GRPR)-targeted PET imaging effectively detected optic pathway gliomas (OPGs) in children. This GRPR-targeted PET/MRI approach shows promise for guiding surgery and potential future therapies for OPGs.
Area of Science:
- Pediatric Neuro-oncology
- Molecular Imaging
- Radiopharmaceuticals
Background:
- Optic pathway glioma (OPG) presents management challenges in pediatric neuro-oncology due to its location and patient age.
- Accurate tumor detection and localization are crucial for effective OPG treatment planning.
Purpose of the Study:
- To assess the feasibility of gastrin-releasing peptide receptor (GRPR)-targeted positron emission tomography (PET) imaging in children with OPG.
- To evaluate the application of a PET/MRI imaging-guided surgery navigation platform for OPG management.
Main Methods:
- Eight children with suspected OPG underwent PET/CT or PET/MRI using 68Ga-NOTA-Aca-BBN(7-14).
- Comparison with 18F-FDG PET was performed in four patients.
- All patients underwent surgical resection, and imaging was fused with a navigation platform.
Main Results:
- 100% of OPG lesions showed prominent 68Ga-NOTA-Aca-BBN(7-14) uptake with excellent contrast.
- GRPR-targeted PET demonstrated significantly higher tumor-to-background ratios than 18F-FDG PET.
- PET/MRI facilitated tumor delineation for surgical planning, and uptake correlated with GRPR expression.
Conclusions:
- 68Ga-NOTA-Aca-BBN(7-14) PET is feasible for OPG detection and localization in children.
- GRPR-targeted PET/MRI can aid surgical planning for symptomatic OPG patients.
- GRPR-targeted PET holds potential for guiding future targeted therapies in OPG.
Purpose:
Optic pathway glioma (OPG) is a rare neoplasm that arises predominantly during childhood. Its location in a sensitive region involving the optic pathways, onset in young patients and controversial therapy choice make the management of OPG a challenge in paediatric neuro-oncology. In this study we assessed gastrin-releasing peptide receptor (GRPR)-targeted positron emission tomography (PET) imaging in children with OPG, and the application of a PET/MRI imaging-guided surgery navigation platform.
Methods:
Eight children (five boys, mean age 8.81 years, range 5-14 years) with suspicion of optic pathway glioma on MRI were recruited. Written informed consent was obtained from all patients and legal guardians. Brain PET/CT or PET/MRI acquisitions were performed 30 min after intravenous injection of 1.85 MBq/kg body weight of 68Ga-NOTA-Aca-BBN(7-14). Four patients also underwent 18F-FDG brain PET/CT for comparison. All patients underwent surgical resection within 1 week.
Results:
All 11 lesions (100%) in the eight patients showed prominent 68Ga-NOTA-Aca-BBN(7-14) uptake with excellent contrast in relation to surrounding normal brain tissue. Tumour-to-background ratios (SUVmax and SUVmean) were significantly higher for 68Ga-NOTA-Aca-BBN(7-14) than for 18F-FDG (28.4 ± 5.59 vs. 0.47 ± 0.11 and 18.3 ± 4.99 vs. 0.35 ± 0.07, respectively). Fusion images for tumour delineation were obtained in all patients using the PET/MRI navigation platform. All lesions were pathologically confirmed as OPGs with positive GRPR expression, and 75% were pilocytic astrocytoma WHO grade I and 25% were diffuse astrocytoma WHO grade II. There was a positive correlation between the SUV of 68Ga-NOTA-Aca-BBN(7-14) and the expression level of GRPR (r2 = 0.56, P < 0.01, for SUVmax; r2 = 0.47, P < 0.05, for SUVmean).
Conclusion:
This prospective study showed the feasibility of 68Ga-NOTA-Aca-BBN(7-14) PET in children with OPG for tumour detection and localization. 68Ga-NOTA-Aca-BBN(7-14) PET/MRI may be helpful for assisting surgery planning in OPG patients with severe symptoms, GRPR-targeted PET has the potential to provide imaging guidance for further GRPR-targeted therapy in patients with OPG.
Related Concept Videos
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Imaging Biological Samples with Optical Microscopy
In optical microscopy, the specimen to be viewed is placed on a glass slide and clipped on the stage...
Other Glycolytic Pathways
Respiration Pathways
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...

